Elgydium Toothpaste Fluorinol® Protect+ 75 ml

Discover Elgydium Toothpaste with exclusive Fluorinol® Protect+ Complex, a daily solution to soothe and protect sensitive teeth. This formula works deep down to reduce discomfort caused by temperature changes and external aggressors.

Enhanced protection and remineralisation

Enriched with the exclusive Fluorinol® Protect+ Complex and Potassium Citrate, this toothpaste helps reduce tooth sensitivity by -90% in 1 month. It supports enamel remineralisation and creates a protective barrier against thermal stimuli. Its immediate and long-lasting action is clinically proven, delivering rapid and lasting relief.

Daily comfort and freshness

Its gentle gel texture, kind to gums and mint-flavoured, freshens breath while providing a cooling sensation. Recommended for adults and children over 12, it fits seamlessly into your oral care routine with brushing 2 to 3 times a day.

This effective yet gentle formula keeps your smile protected.

ELGYDIUM
Toothpaste
Exclusive Fluorinol® Protect+ Complex
For sensitive teeth
75 ml

ELGYDIUM Toothpaste with exclusive Fluorinol® Protect+ Complex is a daily toothpaste that helps reduce tooth sensitivity by promoting enamel remineralisation. It helps effectively protect sensitive teeth from external factors such as heat and cold, and forms a protective barrier that acts as a shield against tooth sensitivity(3). It helps reduce discomfort immediately and lastingly(2) and reduce tooth sensitivity by -90% in 1 month(1). Its formula is enriched with exclusive Fluorinol® Protect+ Complex(4) and Potassium Citrate for immediate(1) enhanced effectiveness.
This gentle gel toothpaste, kind to gums and mint-flavoured, freshens breath and provides a pleasant cooling sensation.
It is recommended to use it by brushing 2 to 3 times a day(1,2), preferably after each meal with a soft-bristled toothbrush.
Suitable for adults and children over 12 years old.
ELGYDIUM, a brand recommended by dentists(5).
(1)Clinical study, cold protection measurement, 44 subjects, 3 applications per day for 4 weeks.
(2)Clinical study, self-assessment, 44 subjects, 3 applications per day for 4 weeks.
(3)In vitro test.
(4)Patent pending.
(5) Imago study 2024, France, 270 responses, 53% recommendation.